It can improve metabolic disorders in obese animals and humans, including decreased insulin sensitivity and glucose and lipid metabolism disorders (Anhê et al., 2015; Dao et al., 2016; Depommier et al., 2019). The gene discussed is INS; the disease is Other metabolic disease.